Email

sara.bedrose@bcm.edu

Positions

Assistant Professor

Medicine
Endocrinology, Diabetes and Metabolism
Baylor College of Medicine
Houston, TX US

Addresses

7200 Cambridge Street (Clinic)

Suite 8B
Houston, TX 77030
United States
Phone: (713) 798-4736

Dan L Duncan Comprehensive Cancer Center (Office)

O’Quinn Medical Tower at Baylor St. Luke’s Medical Center’s McNair Campus
1919 Old Spanish Trail
Houston, TX 77054
United States
Phone: (832) 957-6500
Fax: (713) 610-4597
sara.bedrose@bcm.edu

Baylor St Luke's medical center (Hospital)

6720 Bertner Ave
Houston, TX 77030
United States

Education

MD from Faculty of Medicine, Ain Shams Univeristy

12/2011 - Cairo, Egypt

MS from RUSH University

05/2018 - Chicago, Illinois United States

Residency at John H Stroger Jr Hospital of Cook County

06/2018 - Chicago, Illinois United States

Clinical Fellowship at Baylor College of Medicine

06/2020 - Houston, Texas United States

Research Fellowship at MD Anderson Cancer Center

Houston, Texas United States

Certifications

American board of Internal Medicine

#388158

ABIM

Texas Medical License

#R7663

TMB

Honors & Awards

Glenn Gunnigham award

Award for Clinical Excellence

BCM (06/2020)

Professional Statement

" Endocrinology is the art of using our understanding of the normal physiology to help treat any glandular pathology. Throughout the years, I realized how much I learn more every day of the human body that does not stop teaching us how smart and sophisticated it is ".

Dr. Bedrose graduated from Faculty of Medicine, Ain Shams University in Cairo, Egypt with grade excellent with honors. She completed her Internal Medicine residency at John H. Stroger Jr Hospital of Cook County in Chicago, IL. She earned a Masters of Sciences degree in Clinical Research from RUSH university in Chicago, IL. She then completed her fellowship program in Endocrinology, Diabetes and Metabolism at Baylor college of Medicine and was nominated by her colleagues for the Glenn Cunningham award upon graduation. She holds certification from the American Board of Internal Medicine and is board eligible for the ABIM Endocrinology, Diabetes and Metabolism.

Dr. Bedrose is compassionate about helping patients with disorders of the adrenal gland including adrenal nodules, incidentaloma, indeterminate adrenal nodules, Adrenal cancer, Congenital adrenal hyperplasia in adults . She is also compassionate about helping patients with endocrine neoplasia disorders including Immunotherapy related endocrine side effects. She also treats bone disorders as Osteoporosis, Osteomalacia as well as general endocrine diseases and diabetes.

Selected Publications

• Sara Bedrose, Kevin, Lina Altameemi L , Mohamed S Ali , Sameh Nassar , Naveen Garg , Marilyne Daher , Keith D Eaton, Jeffrey T. Yorio , Davey B Daniel , Matthew Campbell, Keith C Bible , Mabel Ryder , Ashish V Chintakuntlawar, Mouhammed Amir Habra "Combined Lenvatinib and Pembrolizumab as Salvage Therapy in Advanced Adrenal Cortical Carcinoma." Jounral for Immunotherapy of Cancer. 2020 Jul; Pubmed PMID: 32737143
• Bedrose S, Daher M, Altameemi L, Habra MA "Adjuvant therapy in Adrenocortical Carcinoma: Reflections and Future Directions.." Cancers, Volume 12; doi:10.3390/cancers12020508. 2020 Feb;12 Pubmed PMID: 32098326
• Bedrose S, Altameemi L, Daher M, Tamsen G, Varghese J, Jimenez C, Campell M, Habra M "SAT-175 Trial in Progress Interim report: Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma.." Journal of the Endocrine Society doi:10.1210/jendso/bvaa 046.508. 2020 Apr;
• Bedrose S, Turin Moore C, Sang K, Lavis V, Thosani S. "A Case of Acquired Generalized Lipodystrophy associated with Pembrolizumab use in a patient with metastatic malignant melanoma." Endocrine Practice- AACE Jan/Feb 2020, Vol.6, No 1, pp. e40-45. 2020 Jan;6 Pubmed PMID: 32524008

Memberships

ACP

AACE

Endocrine Society

Egyptian Medical Syndicate

Languages

Arabic